Logo image of PFE.DE

PFIZER INC (PFE.DE) Stock Fundamental Analysis

FRA:PFE - Deutsche Boerse Ag - US7170811035 - Common Stock - Currency: EUR

21.09  -0.48 (-2.25%)

Fundamental Rating

5

Taking everything into account, PFE scores 5 out of 10 in our fundamental rating. PFE was compared to 53 industry peers in the Pharmaceuticals industry. PFE has a medium profitability rating, but doesn't score so well on its financial health evaluation. PFE is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year PFE was profitable.
PFE had a positive operating cash flow in the past year.
In the past 5 years PFE has always been profitable.
Each year in the past 5 years PFE had a positive operating cash flow.
PFE.DE Yearly Net Income VS EBIT VS OCF VS FCFPFE.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

1.2 Ratios

PFE has a Return On Assets (3.79%) which is comparable to the rest of the industry.
The Return On Equity of PFE (8.73%) is comparable to the rest of the industry.
The Return On Invested Capital of PFE (6.92%) is comparable to the rest of the industry.
PFE had an Average Return On Invested Capital over the past 3 years of 10.06%. This is significantly below the industry average of 15.20%.
Industry RankSector Rank
ROA 3.79%
ROE 8.73%
ROIC 6.92%
ROA(3y)6.87%
ROA(5y)7.73%
ROE(3y)14.76%
ROE(5y)17.45%
ROIC(3y)10.06%
ROIC(5y)9.93%
PFE.DE Yearly ROA, ROE, ROICPFE.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

With a Profit Margin value of 12.62%, PFE perfoms like the industry average, outperforming 54.72% of the companies in the same industry.
PFE's Profit Margin has declined in the last couple of years.
PFE's Operating Margin of 27.12% is fine compared to the rest of the industry. PFE outperforms 77.36% of its industry peers.
In the last couple of years the Operating Margin of PFE has grown nicely.
PFE's Gross Margin of 74.57% is fine compared to the rest of the industry. PFE outperforms 69.81% of its industry peers.
PFE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 27.12%
PM (TTM) 12.62%
GM 74.57%
OM growth 3Y-8.1%
OM growth 5Y3.31%
PM growth 3Y-22.43%
PM growth 5Y-20.41%
GM growth 3Y6.09%
GM growth 5Y-1.57%
PFE.DE Yearly Profit, Operating, Gross MarginsPFE.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so PFE is still creating some value.
The number of shares outstanding for PFE has been increased compared to 1 year ago.
Compared to 5 years ago, PFE has more shares outstanding
Compared to 1 year ago, PFE has an improved debt to assets ratio.
PFE.DE Yearly Shares OutstandingPFE.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B
PFE.DE Yearly Total Debt VS Total AssetsPFE.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B

2.2 Solvency

An Altman-Z score of 2.14 indicates that PFE is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.14, PFE is not doing good in the industry: 60.38% of the companies in the same industry are doing better.
PFE has a debt to FCF ratio of 5.54. This is a neutral value as PFE would need 5.54 years to pay back of all of its debts.
PFE has a Debt to FCF ratio (5.54) which is comparable to the rest of the industry.
PFE has a Debt/Equity ratio of 0.65. This is a neutral value indicating PFE is somewhat dependend on debt financing.
PFE's Debt to Equity ratio of 0.65 is in line compared to the rest of the industry. PFE outperforms 50.94% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 5.54
Altman-Z 2.14
ROIC/WACC0.76
WACC9.11%
PFE.DE Yearly LT Debt VS Equity VS FCFPFE.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.3 Liquidity

A Current Ratio of 1.26 indicates that PFE should not have too much problems paying its short term obligations.
PFE has a worse Current ratio (1.26) than 64.15% of its industry peers.
PFE has a Quick Ratio of 1.26. This is a bad value and indicates that PFE is not financially healthy enough and could expect problems in meeting its short term obligations.
PFE has a Quick ratio of 0.96. This is comparable to the rest of the industry: PFE outperforms 47.17% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.96
PFE.DE Yearly Current Assets VS Current LiabilitesPFE.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

4

3. Growth

3.1 Past

PFE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 126.06%, which is quite impressive.
PFE shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.06% yearly.
PFE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.65%.
PFE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.10% yearly.
EPS 1Y (TTM)126.06%
EPS 3Y-11.06%
EPS 5Y1.06%
EPS Q2Q%12.2%
Revenue 1Y (TTM)11.65%
Revenue growth 3Y-7.84%
Revenue growth 5Y9.1%
Sales Q2Q%-7.82%

3.2 Future

PFE is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -3.69% yearly.
PFE is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -2.58% yearly.
EPS Next Y-2.62%
EPS Next 2Y0.25%
EPS Next 3Y0.22%
EPS Next 5Y-3.69%
Revenue Next Year-0.95%
Revenue Next 2Y-0.65%
Revenue Next 3Y-1.2%
Revenue Next 5Y-2.58%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PFE.DE Yearly Revenue VS EstimatesPFE.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20B 40B 60B 80B 100B
PFE.DE Yearly EPS VS EstimatesPFE.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 7.70, the valuation of PFE can be described as very cheap.
Based on the Price/Earnings ratio, PFE is valued cheaply inside the industry as 90.57% of the companies are valued more expensively.
PFE's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.04.
A Price/Forward Earnings ratio of 7.91 indicates a rather cheap valuation of PFE.
Based on the Price/Forward Earnings ratio, PFE is valued cheaply inside the industry as 90.57% of the companies are valued more expensively.
PFE is valuated cheaply when we compare the Price/Forward Earnings ratio to 37.64, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 7.7
Fwd PE 7.91
PFE.DE Price Earnings VS Forward Price EarningsPFE.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

86.79% of the companies in the same industry are more expensive than PFE, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PFE indicates a rather cheap valuation: PFE is cheaper than 86.79% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 12.53
EV/EBITDA 7.08
PFE.DE Per share dataPFE.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)7.25
EPS Next 2Y0.25%
EPS Next 3Y0.22%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.84%, PFE is a good candidate for dividend investing.
PFE's Dividend Yield is rather good when compared to the industry average which is at 3.00. PFE pays more dividend than 98.11% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.31, PFE pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.84%

5.2 History

The dividend of PFE has a limited annual growth rate of 3.30%.
Dividend Growth(5Y)3.3%
Div Incr Years3
Div Non Decr Years3
PFE.DE Yearly Dividends per sharePFE.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

121.49% of the earnings are spent on dividend by PFE. This is not a sustainable payout ratio.
PFE's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP121.49%
EPS Next 2Y0.25%
EPS Next 3Y0.22%
PFE.DE Yearly Income VS Free CF VS DividendPFE.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B
PFE.DE Dividend Payout.PFE.DE Dividend Payout, showing the Payout Ratio.PFE.DE Dividend Payout.PayoutRetained Earnings

PFIZER INC

FRA:PFE (7/25/2025, 7:00:00 PM)

21.09

-0.48 (-2.25%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)04-29 2025-04-29/bmo
Earnings (Next)08-05 2025-08-05/bmo
Inst Owners67.59%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap119.90B
Analysts70
Price Target25.38 (20.34%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.84%
Yearly Dividend1.43
Dividend Growth(5Y)3.3%
DP121.49%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)34.98%
Min EPS beat(2)32.52%
Max EPS beat(2)37.45%
EPS beat(4)4
Avg EPS beat(4)42.48%
Min EPS beat(4)30.28%
Max EPS beat(4)69.69%
EPS beat(8)8
Avg EPS beat(8)54.64%
EPS beat(12)12
Avg EPS beat(12)42.48%
EPS beat(16)16
Avg EPS beat(16)36.05%
Revenue beat(2)1
Avg Revenue beat(2)-0.52%
Min Revenue beat(2)-2.36%
Max Revenue beat(2)1.31%
Revenue beat(4)3
Avg Revenue beat(4)4.42%
Min Revenue beat(4)-2.36%
Max Revenue beat(4)17.22%
Revenue beat(8)4
Avg Revenue beat(8)1.74%
Revenue beat(12)8
Avg Revenue beat(12)3.33%
Revenue beat(16)10
Avg Revenue beat(16)3%
PT rev (1m)-0.21%
PT rev (3m)-1.66%
EPS NQ rev (1m)3.72%
EPS NQ rev (3m)2.73%
EPS NY rev (1m)-0.26%
EPS NY rev (3m)1.4%
Revenue NQ rev (1m)0.8%
Revenue NQ rev (3m)-0.65%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)-0.76%
Valuation
Industry RankSector Rank
PE 7.7
Fwd PE 7.91
P/S 2.25
P/FCF 12.53
P/OCF 10.05
P/B 1.56
P/tB N/A
EV/EBITDA 7.08
EPS(TTM)2.74
EY12.99%
EPS(NY)2.67
Fwd EY12.64%
FCF(TTM)1.68
FCFY7.98%
OCF(TTM)2.1
OCFY9.95%
SpS9.37
BVpS13.55
TBVpS-4.81
PEG (NY)N/A
PEG (5Y)7.25
Profitability
Industry RankSector Rank
ROA 3.79%
ROE 8.73%
ROCE 9.87%
ROIC 6.92%
ROICexc 7.7%
ROICexgc 36.63%
OM 27.12%
PM (TTM) 12.62%
GM 74.57%
FCFM 17.96%
ROA(3y)6.87%
ROA(5y)7.73%
ROE(3y)14.76%
ROE(5y)17.45%
ROIC(3y)10.06%
ROIC(5y)9.93%
ROICexc(3y)11.54%
ROICexc(5y)11.73%
ROICexgc(3y)46.07%
ROICexgc(5y)42.74%
ROCE(3y)14.48%
ROCE(5y)14.24%
ROICexcg growth 3Y-10.89%
ROICexcg growth 5Y27.11%
ROICexc growth 3Y-24.53%
ROICexc growth 5Y9.97%
OM growth 3Y-8.1%
OM growth 5Y3.31%
PM growth 3Y-22.43%
PM growth 5Y-20.41%
GM growth 3Y6.09%
GM growth 5Y-1.57%
F-Score8
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 5.54
Debt/EBITDA 2.45
Cap/Depr 40.16%
Cap/Sales 4.43%
Interest Coverage 5.35
Cash Conversion 58.69%
Profit Quality 142.33%
Current Ratio 1.26
Quick Ratio 0.96
Altman-Z 2.14
F-Score8
WACC9.11%
ROIC/WACC0.76
Cap/Depr(3y)55.83%
Cap/Depr(5y)55.63%
Cap/Sales(3y)4.78%
Cap/Sales(5y)4.87%
Profit Quality(3y)143.88%
Profit Quality(5y)138.86%
High Growth Momentum
Growth
EPS 1Y (TTM)126.06%
EPS 3Y-11.06%
EPS 5Y1.06%
EPS Q2Q%12.2%
EPS Next Y-2.62%
EPS Next 2Y0.25%
EPS Next 3Y0.22%
EPS Next 5Y-3.69%
Revenue 1Y (TTM)11.65%
Revenue growth 3Y-7.84%
Revenue growth 5Y9.1%
Sales Q2Q%-7.82%
Revenue Next Year-0.95%
Revenue Next 2Y-0.65%
Revenue Next 3Y-1.2%
Revenue Next 5Y-2.58%
EBIT growth 1Y56.33%
EBIT growth 3Y-15.3%
EBIT growth 5Y12.71%
EBIT Next Year21.61%
EBIT Next 3Y6.42%
EBIT Next 5Y3.52%
FCF growth 1Y-44.47%
FCF growth 3Y-30.95%
FCF growth 5Y-0.32%
OCF growth 1Y-41.56%
OCF growth 3Y-26.87%
OCF growth 5Y0.25%